1 citations
,
December 2022 in “PubMed” Psoriasis treatments don't raise severe COVID-19 risk, except for acitretin.
1 citations
,
September 2022 in “TURKDERM” Systemic retinoids do not increase COVID-19 risk or severity.
1 citations
,
January 2022 in “Monaldi archives for chest disease” After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.
1 citations
,
January 2022 in “South Florida Journal of Development” A post-COVID-19 patient in Manaus developed cryptococcal meningitis, highlighting the need for better health education and sanitation.
1 citations
,
July 2021 in “Journal of The American Academy of Dermatology” Face mask-related injuries in U.S. emergency departments rose by 2400% during the COVID-19 pandemic, with most injuries being dermatitis and lacerations.
1 citations
,
January 2021 in “Research Square (Research Square)” The AndroCoV Clinical Scoring is an accurate, easy, and free way to diagnose COVID-19 without a lab test.
1 citations
,
January 2021 in “medRxiv (Cold Spring Harbor Laboratory)” The study concludes that the new clinical scoring system is a quick, low-cost, and accurate method for diagnosing COVID-19.
1 citations
,
September 2020 in “Journal of the Endocrine Society” Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.
April 2026 in “Signal Transduction and Targeted Therapy” Balancing testosterone may reduce COVID-19 severity.
November 2025 in “Preprints.org” New-onset fibromyalgia after COVID-19 is poorly understood and needs more research.
November 2025 in “Journal of Laboratory Medicine” Chronic stress increased after lockdown, especially in young adults and females.
New-onset fibromyalgia after COVID-19 is poorly understood, needing better definitions and studies.
Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.
August 2024 in “Orvosi Hetilap” Vaccination helps prevent long-term COVID-19 symptoms.
February 2024 in “Indian Dermatology Online Journal” Androgenic alopecia is linked to more severe COVID-19 and higher mortality.
January 2024 in “Authorea (Authorea)” Convalescent Plasma Therapy may help treat COVID-19 Long-Hauler symptoms.
January 2024 in “Future postharvest and food” Frankincense may help treat COVID-19, but more research is needed.
Sex hormones may affect COVID-19 severity and outcomes.
November 2023 in “Advances in clinical medical research & healthcare delivery”
November 2023 in “Advances and Applications in Statistics” AI can effectively predict COVID-19 mortality risk using patient data.
September 2023 in “Indian Journal of Postgraduate Dermatology” Few healthcare workers had skin reactions after Covid-19 vaccination.
April 2023 in “International Journal of Community Medicine and Public Health” Older people with severe COVID-19, especially those with certain health conditions, are more likely to experience post-COVID syndrome.
April 2023 in “Mayo Clinic Proceedings” Estrogen may help improve COVID-19 outcomes, especially in women.
April 2023 in “Journal of Investigative Dermatology” During the COVID-19 pandemic in China, skin conditions like eczema and warts increased among children, while respiratory-transmitted skin infections decreased, partly due to mask-wearing.
March 2023 in “Brazilian Journal of Health Review” The combination tablet of finasteride and doxazosin works the same as taking each drug separately.
January 2023 in “Health Sciences” Androgens may worsen COVID-19 severity in men.
October 2022 in “Journal of experimental and clinical medicine” Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.
October 2022 in “Amplla Editora eBooks” The document's conclusion cannot be provided because the content is not available for analysis.
October 2022 in “Amplla Editora eBooks” The document's conclusion cannot be provided because the document is not accessible or understandable.